Prognostic implications derived from ultrasonic tissue characterization with myocardial integrated backscatter in patients with dilated cardiomyopathy

Abstract

Background: Various clinical parameters have been reported to predict survival in patients with dilated cardiomyopathy (DCM). Myocardial ultrasonic integrated backscatter (IB) imaging has a potential to perform in vivo tissue characterization. The present study was performed to examine whether myocardial IB analysis can predict the prognosis of DCM patients. Methods and results: We prospectively carried out echocardiographic examinations with IB analysis in 43 patients with DCM (31 males, 12 females) under the standard treatment. IB analysis was performed in the left ventricular wall and the calibrated (subtracting pericardial data) myocardial IB intensity (IBI) was obtained from the interventricular septum and the left ventricular posterior wall. After the follow-up (8–39 months), 31 followed a good clinical course, but eight had cardiac death, one had partial left ventriculectomy for uncontrolled heart failure and three were hospitalized for worsening heart failure. β-Blocker responded in 27 (87%) of the 31 with good clinical course, but it did not respond in 11 among the 12 with poor course. In these 12 DCM, left ventricular fractional shortening (LVFS) was lower (good: 18±5%, poor: 14±4, P<0.03) and calibrated IBI was higher in both the septum (good: −16.4±5.6 dB, poor: −11.1±4.2 dB, P<0.006) and the posterior wall (good: −19.5±3.6 dB, poor: −13.8±5.6 dB, P<0.004). On the Cox proportional hazard model analysis, only calibrated IBI in the septum >−17 dB, the cut-off score of calibrated IBI discriminating non-responders to β-blocker therapy in our previous report, was related to the poor outcome ( χ 2=4.43, P=0.035). The stepwise multivariate analysis revealed that both calibrated IBI in the septum>−17 dB ( χ 2=4.43, P=0.035) and LVFS<15% ( χ 2=3.89, P=0.049) were useful to predict the poor clinical outcome. The event free rate assessed by the Kaplan–Meier method was also significantly reduced in patients with calibrated IBI in the septum >−17 dB ( χ 2=6.594, P=0.01) and calibrated IBI in the posterior wall>−17 dB ( χ 2=4.215, P=0.04). However, LVFS<15% ( χ 2=3.576, not significant) did not contribute to discriminating the event free rate in the clinical course. Conclusions: The present study demonstrated that myocardial IB intensity was higher in DCM patients who followed a poor clinical course rather than in those with a good outcome. Therefore, it is clarified that myocardial ultrasonic tissue characterization in DCM patients is useful for assessing their clinical outcome after receiving not only the standard treatment but also β-blocker therapy.